Comparing two types of gastric bypass for treating type 2 diabetes
Official title: Efficacy and Safety of One-anastomosis Versus Roux-en-Y Gastric Bypass for Type 2 Diabetes Remission (ORDER): a Multi-centric, Randomized, Open-label, Superiority Trial
Run by Beijing Friendship Hospital · NCT05015283 · Data updated 2026-11-12
This study is testing which type of gastric bypass surgery, one-anastomosis or Roux-en-Y, works better for helping people with obesity and type 2 diabetes lose weight and improve their diabetes.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 248 (estimated) |
| Sponsor | Beijing Friendship Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | February 1, 2022 |
| Main results expected | October 1, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | August 3, 2022 |
| Trial ID | NCT05015283 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are East Asian adults aged 21-65 with obesity and type 2 diabetes who meet specific BMI and diabetes duration criteria.
✕Probably not a fit
Patients with a history of gastrointestinal surgery, serious cardiovascular diseases, or other significant health issues may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to compare the efficacy and safety of one-anastomosis gastric bypass (OAGB) versus Roux-en-Y gastric bypass (RYGB) in patients with type 2 diabetes mellitus (T2DM) who are also dealing with obesity. The study will involve participants aged 21-65 with a BMI between 27.5 and 50 kg/m2, who have been diagnosed with T2DM for at least six months and are currently on diabetes medications. The primary focus will be on weight loss and the effectiveness of these two surgical methods in achieving diabetes remission. The trial is being conducted at Beijing Friendship Hospital and involves collaboration with several other hospitals in China.
Why it matters
Potential benefit: If successful, this study could provide insights into more effective surgical options for achieving diabetes remission in obese patients.
How similar studies have gone: Previous studies have shown promising results for both surgical methods, but this direct comparison is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 21-65 years old, Male/Female, East Asian population * 50 kg/m2≥BMI≥27.5kg/m2 * Type 2 diabetes duration ≥6 months * HbA1c≥7.0% * Currently receiving one or more oral/injectable hypoglycemic drugs (insulin /glucagon-like peptide-1 receptor agonist) * Recommendation for OAGB/RYGB evaluated by a multidisciplinary team Exclusion Criteria: * Underwent gastrointestinal surgery (gastric/duodenal surgery or bariatric surgery) * Fasting C-peptide level lower than 1/2 normal minimum * Active gastrointestinal ulcer is present * Helicobacter pylori infection is present * A history of serious cardiovascular and cerebrovascular diseases (myocardial infarction, stroke, etc.) * A history of cirrhosis (Child-Pugh≥A) * A history of chronic kidney disease (eGFR )\< 60 ml/min / 1.73 m2) * Inflammatory bowel disease is present (ulcerative colitis, Crohn's disease) * Chronic anemia is present, Hgb for male \<100g/L, for female \<90g/L * A desire to conception during the study period * Uncontrolled mental and psychological disorders are present * Expected survival\<5 years of end-stage disease or previous/current malignant tumor * Participated in clinical studies/trials that have the conflict of interest with the study * Unable to understand, refuse to participate and sign the informed consent * Gallstones require cholecystectomy * Reflux esophagitis above grade A
Where it's running
-
Beijing Friendship Hospital
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Principal investigator: Zhongtao Zhang, M.D.;Ph.D — Beijing Friendship Hospital
- Study coordinator: Zhongtao Zhang, M.D.;Ph.D
- Email: zhangzht@ccmu.edu.cn
- Phone: +86-13801060364
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Investigating brain health in youth at risk for type 2 diabetes
This study is trying to see how being overweight or having blood sugar issues affects brain health in kids aged 12-17 who might be at risk for type 2 diabetes.
-
Effects of SGLT2 Inhibitors and Ketones on Heart and Muscle Health
This study is testing if a diabetes medication can change ketone levels in people with Type 2 Diabetes and heart failure to see how it affects their heart and muscle health over 12 weeks.
-
Seeing Diabetes Clearly: multi-organ MRI of organ health in adults with type 2 diabetes
This project will use a detailed abdominal and multi-organ MRI plus blood and urine tests to see if imaging measurements can predict future health events in adults with type 2 diabetes who have not had heart disease.
-
Using iGlucose Device to Improve Blood Sugar Management in Pregnant Women with Diabetes
This study is testing if using the iGlucose device can help pregnant women with diabetes better manage their blood sugar levels compared to regular care.
-
Examining the effects of exercise and liraglutide on blood vessel function in Type 2 diabetes
This study is testing whether exercise, a diabetes medication called liraglutide, or a mix of both can improve blood flow and how well the body uses insulin in people with Type 2 diabetes.
-
Understanding health trends in Puerto Rico
This study is trying to understand health trends in Puerto Rico by looking at diet, mental health, and heart health in adults aged 30-75 over time.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.